Advertisement
Advertisement

KYTX

KYTX logo

Kyverna Therapeutics, Inc. Common Stock

10.78
USD
Sponsored
+0.55
+5.38%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

10.89

+0.11
+1.01%

Kyverna Therapeutics, Inc. Common Stock Profile

About

Kyverna Therapeutics Inc. is a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company's lead product candidate includes KYV-101. Kyverna Therapeutics Inc. is based in EMERYVILLE, Calif.

Info & Links

CEO

Warner Biddle

Headquarters

5980 HORTON STREET, SUITE 550
EMERYVILLE, CA 94608, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://kyvernatx.com

Auditor

BDO USA, P.C.

Share holders

18

Employees

130

Kyverna Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

659.11M

Enterprise Value

560.07M

Enterprise Value/EBITDA(ttm)

-3.33

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.49

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-81.47%

Return on Invested Capital(ttm)

-81.66%

Return on Assets(ttm)

-66.70%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-168.03M

Net Income Available to Common(ttm)

-161.31M

Diluted EPS(ttm)

-3.65

Share Statistics

Beta (5Y Monthly)

2.62

52-Week Change

364.66%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

60.44M

Dividend Yield

0.00%

Float4

47.14M

% Held by Insiders

22.00%

% Held by Institutions

18.08%

Balance Sheet

Total Cash(mrq)

279.25M

Total Cash Per Share(mrq)

4.62

Total Debt(mrq)

25.05M

Total Debt/Equity(mrq)

10.78%

Current Ratio(mrq)

7.75%

Quick Ratio(mrq)

7.75%

Book Value Per Share(mrq)

3.85

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.47

Free Cash Flow(ytd)

-153.65M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement